Girish Putcha, MD, PhD, discusses the utility of blood-based assays in colorectal cancer.
Girish Putcha, MD, PhD
Advertisement
Articles by Girish Putcha, MD, PhD
Girish Putcha, MD, PhD, discusses the results of the AI EMERGE trial (NCT03688906) in colorectal cancer.
Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director, Freenome, discusses blood-based detection of early-stage colorectal cancer (CRC) using multiomics and machine learning.
Girish Putcha, MD, PhD, discusses the use of blood-based screening assays in colorectal cancer (CRC).
Advertisement
Latest Updated Articles
Dr. Putcha on Blood-Based Detection of Early-Stage CRCFebruary 5th 2020
Dr. Putcha on the Use of Blood-Based Screening Assays in CRCFebruary 5th 2020
Dr. Putcha on the Results of the AI EMERGE Trial in CRCFebruary 14th 2020
Dr. Putcha on the Utility of Blood-Based Assays in CRCMarch 13th 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
The OncFive: Top Oncology Articles for the Week of 5/31
3
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
4
Extended Pelvic Lymph Node Dissection Improves MFS in High-Grade Prostate Cancer
5